SUPERION INDIRECT DECOMPRESSION SYSTEM
Report
- Report Number
- 3006630150-2020-06696
- Event Type
- Injury
- Date Received
- January 15, 2021
- Date of Event
- December 21, 2020
- Report Date
- February 11, 2021
- Manufacturer
- VERTIFLEX INC.
- Product Code
- NQO
- UDI-DI
- 00884662000543
- PMA / PMN Number
- P140004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN, US
- Reporter Occupation
- PHYSICIAN
Narratives
IT WAS REPORTED THAT THE PATIENT DEVELOPED A SEROMA AFTER AN IMPLANT PROCEDURE. THE PATIENT WAS MONITORED AND TREATED WITH ANTIBIOTICS. THE PATIENT WAS LATER HOSPITALIZED FOR HIP ISSUES AND HER BACK BEGAN LEAKING PURULENT FLUID. A CULTURE WAS PERFORMED AND IT TESTED POSITIVE FOR AN INFECTION. THE PATIENT WAS TREATED WITH ANTIBIOTICS AND THEN UNDERWENT AN EXPLANT PROCEDURE TO REMOVE BOTH SPACERS. NO PRODUCTS WILL BE RETURNED PER FACILITY POLICY. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT IS HEALING AND SLOWING IMPROVING.
(B)(4). ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: SUPERION IMPLANT, UPN: (B)(4), MODEL: 101-9810, SERIAL: N/A, BATCH: 800306.
IT WAS REPORTED THAT THE PATIENT DEVELOPED A SEROMA AFTER AN IMPLANT PROCEDURE. THE PATIENT WAS MONITORED AND TREATED WITH ANTIBIOTICS. THE PATIENT WAS LATER HOSPITALIZED FOR HIP ISSUES AND HER BACK BEGAN LEAKING PURULENT FLUID. A CULTURE WAS PERFORMED AND IT TESTED POSITIVE FOR AN INFECTION. THE PATIENT WAS TREATED WITH ANTIBIOTICS AND THEN UNDERWENT AN EXPLANT PROCEDURE TO REMOVE BOTH SPACERS. NO PRODUCTS WILL BE RETURNED PER FACILITY POLICY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 74134 | SUPERION INDIRECT DECOMPRESSION SYSTEM | PROSTHESIS, SPINOUS PROCESS SPACER/PLATE | NQO | VERTIFLEX INC. | 101-9812 | 800322 | 00884662000543 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |